SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit (LFIA)

The rapid test is intended for self-testing and for the qualitative detection of SARS-CoV-2 and influenza A and B viruses. The test is performed as a nasal sample using a sterile swab. The result for each virus is shown separately. The result can be read after 15 minutes and should not be read after more than 30 minutes.

The product is an in vitro diagnostic medical device (IVD) that is intended for self-testing by a layperson, CE-marked (1434).

Manufacturer: Jiangsu Medomics Medical Technology Co., Ltd.